The European Medicines Agency (EMA) on Thursday greenlighted the Coronavirus vaccine developed by Johnson & Johnson for use across the EU in people from 18 years of age.
The Belgian-based company Janssen Pharmaceutica, owned by US pharmaceutical giant Johnson & Johnson had applied for a conditional marketing authorisation in mid-February. The European Commission has already agreed for 200 doses with an option to order an extra 200 million. The first jabs could be available in Europe b…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
